NCT05362019 is a NA clinical trial of Compound Norethisterone Enanthate Injection in Contraception Behavior, sponsored by National Research Institute for Family Planning, China.

Who is sponsoring NCT05362019?

NCT05362019 is sponsored by National Research Institute for Family Planning, China.

What drugs are being tested in NCT05362019?

Interventions in NCT05362019: Compound Norethisterone Enanthate Injection, One-to-one Service, Family Planning Service.

What condition does NCT05362019 study?

NCT05362019 studies Contraception Behavior, Contraceptive Usage.

Is NCT05362019 still recruiting?

NCT05362019 is currently status unknown. Last updated 1 May 2022.

Last reviewed 2022-05-01 · How we verify

NCT05362019

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of One-to-one Service on the Continuation and Satisfaction of Combined Injectable Contraceptive Use.

Status unknown NA Last updated 1 May 2022

What this trial tests

NA trial testing Compound Norethisterone Enanthate Injection in Contraception Behavior in 400 participants. Status unknown.

Timeline

1 May 2022

Primary endpoint
1 December 2022

1 March 2023

Quick facts

Lead sponsor	National Research Institute for Family Planning, China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	400
Start date	1 May 2022
Primary completion	1 December 2022
Estimated completion	1 March 2023
Sites	8 locations across China

Drugs / interventions tested

Compound Norethisterone Enanthate Injection — full drug profile →
One-to-one Service
Family Planning Service

Conditions studied

Contraception Behavior — all drugs for Contraception Behavior →
Contraceptive Usage — all drugs for Contraceptive Usage →

Sponsor

National Research Institute for Family Planning, China

Who can join

Adults 18 to 40, female only, with Contraception Behavior or Contraceptive Usage. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Termination rate
Time frame: 6 months
The termination rates of the two groups were observed for 6 months.
Continuation rate
Time frame: 6 months
The continuation rates of the two groups were observed for 6 months.
Satisfaction rates
Time frame: Up to 4 weeks
The satisfaction rates of two groups after a 6 months of contraceptive use.

Sponsor's own description

This study aims to explore the impact of a mobile based one-to-one service model on improving the continuation and satisfaction of combined injectable contraceptive use, and improve the utilization and acceptability of efficient and long-term contraceptive methods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Contraception Behavior

Currently open trials in the same condition.

NCT06943209 — SAPLAI : Assessing the faiSAbility of a Peer-to-peer Contraceptive Education Program on Social Networks Aimed at 15- to · recruiting
NCT06852508 — TwySHE - An Mhealth Peer-navigator Intervention to Increase PrEP and Contraceptive Use · NA · recruiting
NCT06579781 — Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study) · NA · recruiting
NCT06296797 — Patient-centered Information on Permanent Contraception · NA · recruiting
NCT06608862 — The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults · recruiting

Other National Research Institute for Family Planning, China trials

Trials by the same sponsor.

NCT07514377 — JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China · active not recruiting
NCT06203080 — The Contraceptive Efficacy and Safety of an Intravaginal Acetic Acid Thermoreversible Gel on Chinese Women. · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05362019 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Research Institute for Family Planning, China
Last refreshed: 1 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05362019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing